Screening technologies that will advance cell line development

Viral vaccines make up another interesting section of R&D for the vaccine industry. Tell us your opinion on them below! Dr Arifa Khan, Senior Investigator, CBER, FDA joined us at the World Vaccine Congress 2012 in Washington to give a presentation on different types of cell substrates for viral vaccines; Factors to consider for adventitious agent testing; Mitigation strategies for …